In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Zoltan Varga discusses the importance of understanding patient motivations
Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.
While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.
Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.
As AI becomes embedded throughout development, innovation must be matched by equally sophisticated approaches to software security.
Editor's Picks
